AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ozomet-G 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Ozone Pharmaceuticals Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Ozomet-G 2mg/500mg Tablet ER

Glucozym-Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Glucozym-Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, which necessitates a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; be aware of symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe renal or hepatic impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician before use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to track blood cell counts and liver function.

Uses of Ozomet-G 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Ozomet-G 2mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Ozomet-G 2mg/500mg Extended-Release tablet should be administered with a meal.

Common Side effects of Ozomet-G 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ozomet-G 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ozomet-G 2mg/500mg Extended-Release tablet whole; do not crush, chew, or break it. Administer this medication with food.

How Ozomet-G 2mg/500mg Tablet ER works:

Ozomet-G 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ozomet-G 2mg/500mg Extended-Release Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Ozomet-G tablets (2mg/500mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Ozomet-G tablets (2mg/500mg) are contraindicated during lactation due to the potential for infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ozomet-G 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Ozomet-G 2mg/500mg Extended-Release tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

The extended-release Ozomet-G 2mg/500mg tablet requires careful administration in individuals with hepatic impairment. Dosage modification of Ozomet-G 2mg/500mg extended-release tablets may be necessary. Physician consultation is advised. Initiation of Ozomet-G 2mg/500mg extended-release therapy typically begins with a reduced dosage for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Ozomet-G 2mg/500mg Tablet ER :

Should you forget to take your Ozomet-G 2mg/500mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ozomet-G 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Treatment

FAQs on Ozomet-G 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ozomet-G 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Ozomet-G 2mg/500mg Tablet ER and seek immediate medical attention.
Ozomet-G 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Ozomet-G 2mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Ozomet-G 2mg/500mg ER tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually.
Ozomet-G 2mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Ozomet-G 2mg/500mg ER tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Ozomet-G 2mg/500mg Tablet...
79
MRP 97
18% off